- $12.65bn
- $12.02bn
- $1.40bn
U.S. RESEARCH ROUNDUP- Arista Networks, Penumbra, S&P Global
Brief: Penumbra, Inc. Reports Second Quarter 2024 Financial Results
Brief: Penumbra Q2 Revenue USD 299.403 Million Vs. IBES Estimate USD 298.4 Million
Penumbra Inc expected to post earnings of 56 cents a share - Earnings Preview
Brief: Penumbra Q1 Revenue USD 278.655 Million Vs. IBES Estimate USD 274.9 Million
Penumbra Inc expected to post earnings of 38 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Darden Restaurants, Fedex, Nike
U.S. STOCKS ON THE MOVE-Nvidia, Intuitive Machines, Block Inc
U.S. RESEARCH ROUNDUP-Biomarin Pharmaceutical, Intuit, Penumbra
Penumbra Inc reports results for the quarter ended in December - Earnings Summary
Brief: Penumbra Q4 Revenue USD 284.679 Million Vs. IBES Estimate USD 286.6 Million
U.S. STOCKS ON THE MOVE-Boeing, Booking Holdings, Eli Lilly
U.S. STOCKS ON THE MOVE-Walmart, Lyft, CrowdStrike
Medical device stocks rise in relief after Wegovy heart benefits data (updated)
Medical device makers rise on relief after Wegovy obesity trial data
Med-tech cos rise as 'several bullets dodged' in Wegovy trial data
Penumbra Inc reports results for the quarter ended in September - Earnings Summary
Brief: Penumbra Q3 Revenue USD 270.946 Million Vs. IBES Estimate USD 265.3 Million
Penumbra Inc expected to post earnings of 45 cents a share - Earnings Preview